Glenmark Pharma inaugural USD 5-year a tonic for HY sector
26 Jul 2016Glenmark Pharmaceuticals Ltd (/BB/BB) an India-based pharmaceutical company brought some added colour to the Indian USD high yield sector on Monday. The inaugural USD200m 5-year (NC3) issue saw very strong USD1.7bn book coverage and benefitted from the